150 related articles for article (PubMed ID: 35131516)
1. Simplified strategy for developing purification processes for antibody-drug conjugates using cation-exchange chromatography in flow-through mode.
Hendricks R; Reese D; Fedesco M; Chinn M; Zhang J; Hutchinson M
J Chromatogr A; 2022 Mar; 1666():462865. PubMed ID: 35131516
[TBL] [Abstract][Full Text] [Related]
2. Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates.
Zhang Z; Zhou S; Han L; Zhang Q; Pritts WA
MAbs; 2019; 11(6):1113-1121. PubMed ID: 31238787
[TBL] [Abstract][Full Text] [Related]
3. Purification of hydrophobic complex antibody formats using a moderately hydrophobic mixed mode cation exchange resin.
Koehnlein W; Holzgreve A; Schwendner K; Skudas R; Schelter F
J Chromatogr A; 2023 Jan; 1687():463696. PubMed ID: 36508767
[TBL] [Abstract][Full Text] [Related]
4. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
Andris S; Hubbuch J
J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
[TBL] [Abstract][Full Text] [Related]
5. Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.
Liu HF; McCooey B; Duarte T; Myers DE; Hudson T; Amanullah A; van Reis R; Kelley BD
J Chromatogr A; 2011 Sep; 1218(39):6943-52. PubMed ID: 21871630
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Unique Selectivity of Hydrophobic Cation Exchanger Nuvia cPrime for the Removal of a Major Process Impurity: A Case Study with IgM.
He XM; Voß C; Li J
Curr Protein Pept Sci; 2019; 20(1):65-74. PubMed ID: 29046148
[TBL] [Abstract][Full Text] [Related]
7. Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugates.
Santora LC; Hobson AD; Wang L; Wu KX
Anal Methods; 2024 Jun; 16(22):3492-3503. PubMed ID: 38770747
[TBL] [Abstract][Full Text] [Related]
8. Two-stage chromatographic separation of aggregates for monoclonal antibody therapeutics.
Kumar V; Rathore AS
J Chromatogr A; 2014 Nov; 1368():155-62. PubMed ID: 25441350
[TBL] [Abstract][Full Text] [Related]
9. Purification of ADCs by Hydrophobic Interaction Chromatography.
Becker CL; Duffy RJ; Gandarilla J; Richter SM
Methods Mol Biol; 2020; 2078():273-290. PubMed ID: 31643064
[TBL] [Abstract][Full Text] [Related]
10. Factorial screening of antibody purification processes using three chromatography steps without protein A.
Follman DK; Fahrner RL
J Chromatogr A; 2004 Jan; 1024(1-2):79-85. PubMed ID: 14753709
[TBL] [Abstract][Full Text] [Related]
11. Development of a Single-Step Antibody-Drug Conjugate Purification Process with Membrane Chromatography.
Cordova JC; Sun S; Bos J; Thirumalairajan S; Ghone S; Hirai M; Busse RA; Hardt JSV; Schwartz I; Zhou J
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540865
[TBL] [Abstract][Full Text] [Related]
12. [Recent progress of chromatographic techniques for antibody purification].
Liu JW; Tang CW; Xia YR; Bai Q
Se Pu; 2024 Jun; 42(6):533-543. PubMed ID: 38845514
[TBL] [Abstract][Full Text] [Related]
13. Preparative separation of monoclonal antibody aggregates by cation-exchange laterally-fed membrane chromatography.
Madadkar P; Sadavarte R; Butler M; Durocher Y; Ghosh R
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():158-164. PubMed ID: 28477519
[TBL] [Abstract][Full Text] [Related]
14. Resolution of heterogeneous charged antibody aggregates via multimodal chromatography: a comparison to conventional approaches.
Chmielowski RA; Meissner S; Roush D; Linden TO; Glowacki E; Konietzko J; Nti-Gyabaah J
Biotechnol Prog; 2014; 30(3):636-45. PubMed ID: 24692271
[TBL] [Abstract][Full Text] [Related]
15. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
Chapel S; Rouvière F; Sarrut M; Heinisch S
Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
[TBL] [Abstract][Full Text] [Related]
16. Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody-Drug Conjugates.
Nadkarni DV; Lee J; Jiang Q; Patel V; Sriskanda V; Dutta K; Meyer DM
Mol Pharm; 2021 Mar; 18(3):889-897. PubMed ID: 33470823
[TBL] [Abstract][Full Text] [Related]
17. Integrated flow-through purification for therapeutic monoclonal antibodies processing.
Ichihara T; Ito T; Kurisu Y; Galipeau K; Gillespie C
MAbs; 2018; 10(2):325-334. PubMed ID: 29271693
[TBL] [Abstract][Full Text] [Related]
18. Multi-step high-throughput conjugation platform for the development of antibody-drug conjugates.
Andris S; Wendeler M; Wang X; Hubbuch J
J Biotechnol; 2018 Jul; 278():48-55. PubMed ID: 29733878
[TBL] [Abstract][Full Text] [Related]
19. Analyzing protein conjugation reactions for antibody-drug conjugate synthesis using polarized excitation emission matrix spectroscopy.
de Faria E Silva AL; Ryder AG
Biotechnol Bioeng; 2022 Dec; 119(12):3432-3446. PubMed ID: 36071600
[TBL] [Abstract][Full Text] [Related]
20. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
